TRANSCODE THERAPEUTICS INC

Historical 13F Holders

Symbol
RNAZ
CUSIP
89357L402
All holders as of
Q1 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 89357L402 since 12/18/2024, newest first.

Filer % of Class Filed
Anson Funds Management LP 13G/A Amendment 1
0.1% 8/14/2025
Event 6/30/2025
Thomas Joseph Tracy 13D 5.0% 3/20/2025
Event 3/7/2025
Anson Funds Management LP 13G
9.9% 2/14/2025
Event 12/31/2024
Sabby Management, LLC 13G
9.9% 1/3/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 20 2.14 M $1.06 M
2024 Q4 6 9.91 k $33.4 k